Help


from Wikipedia
« »  
* Robyn J. Barst, MD ; Stuart Rich, MD, FCCP ; Allison Widlitz, MS, PA ; Evelyn M. Horn, MD ; Vallerie McLaughlin, MD and Joyce McFarlin, RN: Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension Chest.
2002 ; 121: 1860-1868.

2.327 seconds.